| | |
Julia Harper: | | Well David, sometimes there is just a shift in when deliveries happen. You certainly shouldn’t read into this if there’s any kind of downward trend for enterprise, we do expect enterprise revenues to be back up next quarter. It’s just some times the timing of the shipment, and when they need product, and how much inventory they’re holding can influence a little bit from quarter-to-quarter, but absolutely no concerning trends at all that we’re seeing in the enterprise space. |
| | |
David Duley: | | Okay, on to the next topic. You kind of guided top line, when you back out the $3.1 million, you are kind of guiding your top line from, let’s say $58 million to the guidance you gave us, up slightly I guess, and I don’t expect you to spend six hundred and something thousand dollars on acquisition-related costs, that’s about $0.02 fully taxed, so why wouldn’t we see a couple of penny increase here if we had a one-time thing in Q1 and no one-time events in Q2? |
| | |
Julia Harper: | | No, it’s the gross margin David. We said the gross margin would be down about a point and a half quarter-to-quarter. |
| | |
David Duley: | | So, your talking gross margins from 30% down to 27%. |
| | |
Julia Harper: | | No, I am talking gross margins down from the 32.5%, which is normalized without the $3.1 million inventory sale, from 32.5% down to about a point and a half from there. |
| | |
David Duley: | | Okay, so margins will be similar, didn’t you report, like 30% margins this quarter? |
| | |
Julia Harper: | | It was 31%. |
| | |
David Duley: | | So, margins will be down just a little bit, and there would not be a nonrecurring expense of $600 grand in Q2. That part’s accurate, right? There’s no more unusual nonrecurring stuff happening in Q2? |
| | |
Julia Harper: | | Well, so remember I talked about the ESPP expense, we had about $130 thousand that hit in Q1. We’re going to have about $380 thousand that will hit in Q2. |
| | |
David Duley: | | Okay, so the combination of that plus margins being down would lead to EPS being somewhat flatter even though revenue is supposed to be higher? |
| | |
Julia Harper: | | Right. |
| | |
David Duley: | | I got you. What....help us understand why margins would be down in transferring a product to a lower-cost region. And I guess I can understand if the you are positive that your volumes are running ahead of expectations, help me understand why it’s going to impact margins when you move your products there? |
| | |
Scott Grout: | | Two drivers are associated with that. One is, of course, it doesn’t move in one week or one month. It takes a period of time to qualify the particular code, get it up and operational. So, one of the elements of degradation is just related to it staying in its current manufacturing location and not yet being transferred to our China-based EMS. And then. second, we do incur cost associated with making the transfer of the code successfully from current manufacturing site to the new site. |
| | |
David Duley: | | And final question from me, I don’t know if there’s new disclosures where you have to tell us how much you spent on M&A activity, but $600 grand is an awful lot of money to spend for a company your size to be spending on an M&A activity, particularly when you have an in-house corporate development person. So, could you help us understand where the $600 grand was? I don’t want yo.....you can’t tell me what you did the work on but, how did the $600 grand break out amongst the various buckets of fees? |